Related Experiment Video
Updated: Dec 20, 2025

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
Published on: June 29, 2014
[The regulatory mechanism of Raf/MEK/ERK pathway on the rat cardiac hypertrophy induced by transverse aortic
Dan-Ting Fu1, Jue Tu1, Yue-Qin Cai1
1Laboratory Animal Research Center/Institute of Comparative Medicine Zhejiang Chinese Medical University, Hangzhou 310053.
Objective:
To investigate the mRNA, protein expression levels and the phosphorylation levels of key factors in rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular regulated protein kinases (Raf/MEK/ERK) pathway, and to clarify the regulatory function of Raf/MEK/ERK pathway in myocardial hypertrophy.
Methods:
Twenty SD rats were divided into sham-operated group and model group. The myocardial hypertrophy model was established by transverse aortic constriction (TAC). At 12 weeks after TAC, blood samples were collected from the submandibular vein, and the serum was separated to detect the content of N terminal pro B type natriuretic peptide (NT-proBNP). After that, the rats were subjected to echocardiography and hemodynamic measurement. Then the pathological changes of myocardial tissue were observed. And the levels of mRNA, protein expression and the phosphorylation of key factors in Raf/MEK/ERK pathway were detected in myocardial tissue.
Results:
Compared with sham-operated group, left ventricular end-diastolic interventricular septal thickness (IVSd), left ventricular end-systolic interventricular septal thickness (IVSs), left ventricular end-diastolic posterior wall thickness (LVPWd) and left vebtricular end-systolic posterior wall thickness (LVPWs) in TAC model group were increased significantly (P<0.05,P<0.01), left ventricular end-systolic diameter (LVIDs) was decreased significantly (P<0.01), LV Mass and LW(LV Mass/Weight)were increased significantly (P<0.05, P<0.01). The levels of heart rate (HR), left ventricular pressure maximal rate of rise (+dp/dtmax), left ventricular pressure maximal rate of fall (-dp/dtmax) were decreased significantly (P<0.01). The serum level of NT-proBNP in TAC rat was increased significantly (P<0.01). The myocardial cells in TAC model group were arranged disorderly, myocardial cell hypertrophy, cytoplasm were increased significantly, and inflammatory cells infiltrated. A large amount of collagen fibers were deposited and large area of myocardial cells were stained blue in TAC rat. The expression levels of phospho-c-Raf (Ser259) and phospho-c-Raf (Ser338) in myocardial tissue were significantly increased (P<0.01), meanwhile the expression levels of phospho- MEK1/2(Ser217/Ser221) and phospho-ERK1/2 (Thr202/Tyr204) were also significantly increased (P<0.01).
Conclusion:
The regulatory role of Raf / MEK / ERK pathway in cardiac hypertrophy may be through the activation of phosphorylation of c-raf, MEK1, Mek2, ERK1 and ERK2 at specific sites.
Insights
The rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular regulated protein kinases (Raf/MEK/ERK) pathway is activated in cardiac hypertrophy. This pathway
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Signaling
Background:
- Cardiac hypertrophy is a significant risk factor for heart failure.
- The mitogen-activated protein kinase (MAPK) signaling pathways play crucial roles in cardiac adaptation.
- The Raf/MEK/ERK pathway is a key MAPK cascade involved in cellular processes.
Purpose of the Study:
- To investigate the expression and phosphorylation of key factors in the Raf/MEK/ERK pathway in a rat model of cardiac hypertrophy.
- To elucidate the regulatory role of the Raf/MEK/ERK pathway in the development of myocardial hypertrophy.
Main Methods:
- A rat model of cardiac hypertrophy was established using transverse aortic constriction (TAC).
- Echocardiography, hemodynamic measurements, and serum NT-proBNP levels were assessed.
- Myocardial tissue was analyzed for mRNA, protein expression, and phosphorylation of Raf/MEK/ERK pathway components.
Main Results:
- TAC induced significant cardiac hypertrophy, characterized by increased ventricular wall thickness and cardiac mass.
- Hemodynamic dysfunction and elevated NT-proBNP levels were observed in the TAC group.
- Increased phosphorylation of c-Raf, MEK1/2, and ERK1/2 was detected in the hypertrophied myocardium.
Conclusions:
- The Raf/MEK/ERK pathway is activated in cardiac hypertrophy.
- Activation of the Raf/MEK/ERK pathway, via phosphorylation of its key components, plays a regulatory role in myocardial hypertrophy.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply

